| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
0.67 |
Evidence |
|
| P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.67 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
GNAI2 |
Galphai2 protein |
0.67 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.67 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
BMX |
IPI00514142 |
0.67 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.67 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.67 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.67 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
BMX |
IPI00514142 |
0.67 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.67 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
BMX |
IPI00514142 |
0.67 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.67 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.67 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.67 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.67 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
0.67 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.67 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.67 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.67 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.67 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.67 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNAI2 |
Galphai2 protein |
0.67 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.67 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.67 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.67 |
Evidence |
|